Financials
- Market Capitalization 69.88 M
- Employee 25
- Founded 2013
- CEO Ankit Mahadevia
- Website www.sperotherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00HXSJ1R2
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4107 | CRDF Cardiff Oncology, Inc. - Common Stock | 0.94 USD | -5.05% | +1.08% | +17.50% | -55.66% | 73.13 M USD | ||
| 4115 | MNOV MediciNova, Inc. - Common Stock | 1.44 USD | +1.41% | +3.60% | +11.63% | +7.46% | 70.88 M USD | ||
| 4125 | PLRX Pliant Therapeutics, Inc. - Common Stock | 1.11 USD | -3.48% | -2.63% | +2.78% | -31.48% | 68.73 M USD | ||
| 4127 | XBIT XBiotech Inc. - Common Stock | 2.27 USD | -1.30% | -0.44% | -2.16% | -33.04% | 69.21 M USD |
Frequently asked questions about Spero Therapeutics, Inc. Common Stock
What is the Spero Therapeutics, Inc. Common Stock stock price today?
The current price of Spero Therapeutics, Inc. Common Stock (SPRO) is 1.20. Over the past 24 hours, the stock has changed by -0.83%. Follow the SPRO chart for real-time price dynamics.
What is the stock ticker of Spero Therapeutics, Inc. Common Stock?
Spero Therapeutics, Inc. Common Stock trades under the ticker SPRO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Spero Therapeutics, Inc. Common Stock stock going up?
SPRO has changed by -1.64% over the last week, 0.00% over the last month, and -40.30% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Spero Therapeutics, Inc. Common Stock?
Spero Therapeutics, Inc. Common Stock currently has a market capitalization of 69.88 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Spero Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Spero Therapeutics, Inc. Common Stock reported earnings of -0.16 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Spero Therapeutics, Inc. Common Stock revenue for the last quarter?
Spero Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Spero Therapeutics, Inc. Common Stock net income for the last quarter?
Spero Therapeutics, Inc. Common Stock reported net income of -9.55 M for the last quarter. The previous quarter showed -7.2 M, which means net income changed by -32.61%.
How many employees does Spero Therapeutics, Inc. Common Stock have?
As of the latest available data, Spero Therapeutics, Inc. Common Stock has 25 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Spero Therapeutics, Inc. Common Stock stock?
You can buy Spero Therapeutics, Inc. Common Stock (SPRO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Spero Therapeutics, Inc. Common Stock stock?
Investing in Spero Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SPRO chart and related analysis on metatrader.com as part of your research.